Parth Mehrotra Sells 26,763 Shares of Privia Health Group (NASDAQ:PRVA) Stock

Key Points

• CEO Parth Mehrotra sold a total of 138,528 shares across trades from March 6–13, generating about $3.11 million and reducing his holdings to 609,181 shares (a 4.21% cut).
• Privia beat quarterly estimates with $0.25 EPS vs. $0.04 expected and revenue of $541.17M (up 17.4% year-over-year), while the stock trades near $21.96 with a $2.72B market cap.
• Analyst sentiment is broadly positive — 13 Buys and 3 Holds with an average price target of $31 — and institutional investors own roughly 94.48% of the shares.

Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) CEO Parth Mehrotra sold 26,763 shares of the business's stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $21.90, for a total transaction of $586,109.70. Following the sale, the chief executive officer directly owned 609,181 shares in the company, valued at approximately $13,341,063.90. The trade was a 4.21% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Parth Mehrotra also recently made the following trade(s):

• On Friday, March 13th, Parth Mehrotra sold 27,229 shares of Privia Health Group stock. The shares were sold at an average price of $21.52, for a total transaction of $585,968.08.
• On Tuesday, March 10th, Parth Mehrotra sold 21,097 shares of Privia Health Group stock. The shares were sold at an average price of $22.71, for a total transaction of $479,112.87.
• On Monday, March 9th, Parth Mehrotra sold 41,999 shares of Privia Health Group stock. The stock was sold at an average price of $22.86, for a total value of $960,097.14.
• On Friday, March 6th, Parth Mehrotra sold 21,440 shares of Privia Health Group stock. The stock was sold at an average price of $23.15, for a total value of $496,336.00.

Privia Health Group Stock Performance

Shares of NASDAQ PRVA traded up $0.28 during midday trading on Monday, reaching $21.96. The stock had a trading volume of 633,287 shares, compared to its average volume of 805,784. The firm has a market cap of $2.72 billion, a price-to-earnings ratio of 129.18, a price-to-earnings-growth ratio of 1.37 and a beta of 0.82. Privia Health Group, Inc. has a twelve month low of $18.77 and a twelve month high of $26.51. The company's 50 day moving average price is $22.89 and its 200 day moving average price is $23.61.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last announced its earnings results on Thursday, February 26th. The company reported $0.25 EPS for the quarter, beating the consensus estimate of $0.04 by $0.21. The company had revenue of $541.17 million for the quarter, compared to analyst estimates of $516.61 million. Privia Health Group had a return on equity of 3.06% and a net margin of 1.08%.The firm's revenue for the quarter was up 17.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.21 EPS. Equities analysts forecast that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. Piper Sandler reiterated an "overweight" rating and issued a $36.00 target price on shares of Privia Health Group in a research note on Thursday, February 26th. Wolfe Research set a $31.00 price target on shares of Privia Health Group in a research report on Tuesday, January 6th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Privia Health Group in a research report on Monday, December 29th. Jefferies Financial Group reiterated a "buy" rating and issued a $32.00 price objective on shares of Privia Health Group in a research note on Thursday, February 26th. Finally, Canaccord Genuity Group lifted their target price on shares of Privia Health Group from $34.00 to $35.00 and gave the stock a "buy" rating in a research report on Friday, February 27th. Thirteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $31.00.

Institutional Investors Weigh In On Privia Health Group

Several institutional investors have recently added to or reduced their stakes in PRVA. Great Lakes Advisors LLC purchased a new position in shares of Privia Health Group in the third quarter valued at $4,487,000. Advantage Alpha Capital Partners LP purchased a new stake in Privia Health Group during the 2nd quarter worth about $3,941,000. Hsbc Holdings PLC boosted its stake in Privia Health Group by 69.2% in the 2nd quarter. Hsbc Holdings PLC now owns 113,718 shares of the company's stock worth $2,549,000 after purchasing an additional 46,526 shares during the period. Edgestream Partners L.P. bought a new position in Privia Health Group in the 2nd quarter worth about $2,209,000. Finally, Capital Fund Management S.A. purchased a new position in Privia Health Group during the 2nd quarter valued at about $656,000. 94.48% of the stock is owned by hedge funds and other institutional investors.

About Privia Health Group

Privia Health Group NASDAQ: PRVA is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.